Morpholine → HCID 178427390, compound
Reaction equation
[NH2:1][C:2]1[N:6]([C:7]2[CH:16]=[CH:15][C:10]3[NH:11][C:12]([CH3:14])=[N:13][C:9]=3[CH:8]=2)[N:5]=[CH:4][C:3]=1[C:17]([C:19]1[N:20]([S:31]([C:34]2[CH:39]=[CH:38][C:37]([CH3:40])=[CH:36][CH:35]=2)(=[O:33])=[O:32])[C:21]2[C:26]([CH:27]=1)=[CH:25][C:24]([C:28]([OH:30])=O)=[CH:23][CH:22]=2)=[O:18].[NH:41]1[CH2:46][CH2:45][O:44][CH2:43][CH2:42]1.Cl.CN(C)CCCN=C=NCC>O.O1CCCC1>[NH2:1][C:2]1[N:6]([C:7]2[CH:16]=[CH:15][C:10]3[NH:11][C:12]([CH3:14])=[N:13][C:9]=3[CH:8]=2)[N:5]=[CH:4][C:3]=1[C:17]([C:19]1[N:20]([S:31]([C:34]2[CH:35]=[CH:36][C:37]([CH3:40])=[CH:38][CH:39]=2)(=[O:33])=[O:32])[C:21]2[C:26]([CH:27]=1)=[CH:25][C:24]([C:28]([N:41]1[CH2:46][CH2:45][O:44][CH2:43][CH2:42]1)=[O:30])=[CH:23][CH:22]=2)=[O:18]Participants
6
Procedure
2-[5-Amino-1-(2-methyl-1H-benzimidazol-5-yl)-1H-pyrazole-4-carbonyl]-1-(toluene-4-sulfonyl)-1H-indole-5-carboxylic acid (113 mg) was dissolved in water (5 ml) and tetrahydrofuran (THF) (10 ml), and then morpholine (53.5 μl) and N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (WSC-HCl) (43 mg) were added thereto. The mixture was stirred at room temperature for 24 hours. The reaction mixture was then concentrated under reduced pressure. The resulting residue was purified by silica gel column chromatography (methanol/dichloromethane=0/100 to 17/100) to give [5-amino-1-(2-methyl-1H-benzimidazol-5-yl)-1H-pyrazol-4-yl]-[5-(morpholine-4-carbonyl)-1-(toluene-4-sulfonyl)-1H-indol-2-yl]-methanone (59 mg).
Workup
- concentrationThe reaction mixture was then concentrated under reduced pressure
- customThe resulting residue was purified by silica gel column chromatography (methanol/dichloromethane=0/100 to 17/100)
Sources & evidence
- ORD record
- ord-cb721b3edd994086806080529939cc06
- Source dataset
- uspto-grants-2015_08
- Patent number
- US09102692B2
Reaction notes
Loading…